Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson’s disease

11 Apr 2007

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autism Spectrum Disorder Research
Share to Neuroscience and Neuropharmacology Research
Share to Parkinson's Disease Mechanisms and Treatments

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 17499513
DOI: 10.1016/j.nbd.2007.03.013

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson’s diseasePMID 17499513Read ↗

3,4-Dihydroxyphenylalanine Reverses the Motor Deficits in Pitx3-Deficient<i>Aphakia</i>Mice: Behavioral Characterization of a Novel Genetic Model of Parkinson's DiseaseSemantic proximity Read ↗

Experimental models of Parkinson's disease: Challenges and OpportunitiesSemantic proximity Read ↗

Folic Acid Supplementation Ameliorates Oxidative Stress, Metabolic Functions and Developmental Anomalies in a Novel Fly Model of Parkinson’s DiseaseSemantic proximity Read ↗

New ideas on the origin of l-dopa-induced dyskinesias: age, genes and neural plasticitySemantic proximity Read ↗

Striatal neuroadaptation and rescue of locomotor deficit by L-dopa in aphakia mice, a model of Parkinson's disease.Semantic proximity Read ↗

Characterization of Atp1a3 mutant mice as a model of rapid-onset dystonia with parkinsonismSemantic proximity Read ↗

Nigral injection of a proteasomal inhibitor, lactacystin, induces widespread glial cell activation and shows various phenotypes of Parkinson’s disease in young and adult mouseSemantic proximity Read ↗

Experimental models of Parkinson's diseaseSemantic proximity Read ↗

L-DOPA-Induced Dyskinesia in a Genetic Drosophila Model of Parkinson's DiseaseSemantic proximity Read ↗

The Kynurenine Pathway Modulates Neurodegeneration in a Drosophila Model of Huntington's DiseaseSemantic proximity Read ↗

Genetic effects in a progressive model of parkinsonism induced by reserpineSemantic proximity Read ↗

The search for genetic mouse models of prodromal Parkinson's diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.